Hyperuricemia
Conditions
Interventions
Trial group:Drug intervention
control group:no intervention
Sponsors
Huadong Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. After stopping high purine and high protein diet for 2 weeks or antiuricemic drugs for 2 weeks, the fasting blood uric acid was measured twice on different days: 420 µ mol / L (7Mg / dl) 540 µ mol / L (9mg / dl); according to the classification and diagnostic criteria of hyperuricemia, it belongs to the type of poor uric acid excretion; 2. Male, 18-75 years old; 3. Asymptomatic hyperuricemia patients had no gout arthritis, gout stone, uric acid kidney stone and other gout clinical manifestations; 4. Patients with single TCM damp heat constitution type; 5. The subjects must voluntarily participate in the study and abide by the research regulations, understand and abide by the dosage and follow-up plan, and voluntarily sign the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with allergic constitution or allergic to this drug, and those with weak constitution; 2. Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, and mental patients; 3. Patients with secondary hyperuricemia, such as leukemia, myeloma, renal failure, polycystic kidney disease, some endocrine diseases, some drugs such as diuretics, aspirin, antituberculosis drugs, etc; 4. Patients who fail to use drugs and complete treatment according to the regulations, unable to judge the efficacy or incomplete data, which affect the efficacy or safety judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum uric acid; | — |
Countries
China
Contacts
Public ContactWang Xiaojun
Huadong Hospital
Outcome results
None listed